®Ú¾Ú²Îp¡A¥þ²yÂåÀø¥«³õ¨C¦~¥H7%ªº³t«×éw¦¨ªø¡A¥[¤Wªñ¨Óºë·ÇÂåÀø°Ó¾÷¤jÃzµo¡A¥«³õ¹w¦ô¦Ü2030¦~ªº¦~½Æ¦X¦¨ªø²v§ó¤W¬Ý19%¡C±M§ðÀù¯g°ò¦]ÀË´ú§Þ³Nªº¦æ°Ê°ò¦]±±ªÑ¤½¥q(ACT Genomics
Holdings Company Limited)©ó¤é«e§¹¦¨³Ì·s¤@½ü¶Ò¸ê¡A¦¹½ü§ë¸ê¤è¥Dn¨Ó¦Û¥]§t»´ä¡B·s¥[©Y¤Î¤é¥»ªº°ê»Ú³Ð§ë¤½¥q¡A¦¨¥\¶Ò¸ê±N¥[§Ö¦æ°Ê°ò¦]ÂX®i°ê»Úª©¹Ï³t«×¡C
³¯µØÁä ³Õ¤h
¦æ°Ê°ò¦]³Ð¿ì¤Hº[°õ¦æªø³¯µØÁä³Õ¤hªí¥Ü¡A¦æ°Ê°ò¦]¬O¨È¬w»â¥ýªºÀù¯g¥ÎÃÄ°ò¦]ÀË´ú¤½¥q¡A±M§ðÀù¯g°ò¦]ÀË´ú¤ÎÀËÅç§Þ³N¡A¥i´À¯f¤HÀˬd¥XÀù¯g¦]¤l¡A¨Ã¥Bºë·Ç¥ÎÃÄ¡A¥«³õ¼ç¤O«D±`¤j¡C³o¦¸¨ì¦ìªº·s¸êª÷¡A¯à¥[³t¦æ°Ê°ò¦]¹ê½îµ¦²¤¥Ø¼Ð¡A²`¤Æ¨È¬w§G§½¤Î¯à¤O¡A¦P®É«ùÄòÂX®i°Ó·~ª©¹Ï¡A¥]¬A¦b»´ä«Ø¥ß¨ãCAP»{ÃÒªº¦¸¥@¥N©w§ÇÀË´ú¹êÅç«Ç¡B·s²£«~¬ãµo¡B©Ý®i¨È¬wÁ{§ÉªA°ÈÀç¹B¡A¨Ã»P¥þ²y¤Î°Ï°ì©Êªº¥Íª«»sÃĤ½¥q¶i¦æÃĪ«¶}µo¦X§@¡C
°ò¦]ÀË´ú¬O±N¨C¦ìÀù¯g¯f±wªº°ò¦]¸ê°TÂà¤Æ¬°¥ÎÃĸê°T¡A´£¨ÑÁ{§ÉÂå®v»P¯f±w¨ãÂå¾Ç¹êÃÒªº¥ÎÃÄ¿ï¾Ü¸ê°T¹ï§ÜÀù¯g¡A³z¹L¦¸¥@¥N©w§Ç§Þ³N(Next Generation Sequencing¡ANGS)¡B¨È¬w¤H¸ê®Æ®w¡B¨È¬w±M·~¥ÍÂå¡B¥Íª«¸ê°T¹Î¶¤¡BÂåÃÄÀË´ú³ø§i¤Î¾ã¦XªA°È¡A´£¨Ñ¨C¤@¦ìÀù¯g¯f±wÓ¤H¤ÆªºÀù¯g¥ÎÃĸê°T¡C¦æ°Ê°ò¦]¥Ø«e¦b¥xÆW¡B»´ä¡B·s¥[©Y¡B¤é¥»¬Ò³]¦³¤À¤½¥q¡A¨Ã»P¤é¥»ª¾¦W¥ø·~ Canon¨Î¯à¶°¹ÎºX¤Uªº¨Î¯àÂåÀø(Canon Medical System
Corporation)¦X¸ê¦b¤é¥»¦¨¥ß¤À¤½¥q¡A«ùÄò¦b¤é¥»´£¨ÑÀù¯g°ò¦]ÀË´úªA°È¤Î©w§Ç¸ê®Æ¤ÀªR¡C
³¯µØÁä³Õ¤h»¡©ú¡A¦æ°Ê°ò¦]¦¨¥ß©ó2014¦~¡A´£¨ÑÀù¯g¸Ñ¨M¤è®×¡BÀù¯g´_µo»P§ÜÃĩʺʱ±¤ÎÀù¯g·ÀI»P§K¬ÌªvÀøµû¦ô¡C³z¹L·L¶q¸~½FÀËÅéºë·Ç°»´ú¥XÀù¯g°ò¦]¬ðÅÜ¡A¨Ã³z¹L¦yºÝ¦¸¥@¥N©w§Ç§Þ³N¡BÂåÃijø§i¤Î¾ã¦XªA°È´£¨ÑÀù¯g¯f±wÓ¤H¤ÆÂåÀø¡F¦¹¥~¡A¦æ°Ê°ò¦]¦bÀù¯g°ò¦]Åé¾Ç¾É¤J¤H¤u´¼¼z¨Ã¾ã¦X¨È¬w¤H°ò¦]¸ê®Æ®w´£¨Ñ§¹¾ãªºÀù¯g¤À¤l¸ê°T¡A§¹¾ãªºÀË´úªA°ÈÀò±o2017 Frost & Sullivan¨È¤Ó¤À¤l¶EÂ_²£«~µ¦²¤»â¾É¼ú¡C
|